NO20050179L - Identifisering av oligonukleotider for oppfanging, deteksjon og kvantifisering av Hepatitt A viral nukleinsyre - Google Patents

Identifisering av oligonukleotider for oppfanging, deteksjon og kvantifisering av Hepatitt A viral nukleinsyre

Info

Publication number
NO20050179L
NO20050179L NO20050179A NO20050179A NO20050179L NO 20050179 L NO20050179 L NO 20050179L NO 20050179 A NO20050179 A NO 20050179A NO 20050179 A NO20050179 A NO 20050179A NO 20050179 L NO20050179 L NO 20050179L
Authority
NO
Norway
Prior art keywords
hepatitis
nucleic acid
oligonucleotides
capture
quantification
Prior art date
Application number
NO20050179A
Other languages
English (en)
Norwegian (no)
Inventor
Venkatakrishna Shyamala
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of NO20050179L publication Critical patent/NO20050179L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10Modifications characterised by
    • C12Q2525/15Modifications characterised by incorporating a consensus or conserved sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00Reactions characterised by their quantitative nature
    • C12Q2545/10Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/114Reactions characterised by their quantitative nature the purpose being quantitative analysis involving a quantitation step
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/143Magnetism, e.g. magnetic label
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Saccharide Compounds (AREA)
NO20050179A 2002-06-12 2005-01-12 Identifisering av oligonukleotider for oppfanging, deteksjon og kvantifisering av Hepatitt A viral nukleinsyre NO20050179L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38854402P 2002-06-12 2002-06-12
PCT/US2003/018827 WO2003106641A2 (en) 2002-06-12 2003-06-12 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid

Publications (1)

Publication Number Publication Date
NO20050179L true NO20050179L (no) 2005-03-09

Family

ID=29736491

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050179A NO20050179L (no) 2002-06-12 2005-01-12 Identifisering av oligonukleotider for oppfanging, deteksjon og kvantifisering av Hepatitt A viral nukleinsyre

Country Status (21)

Country Link
US (2) US20040072150A1 (es)
EP (1) EP1552022B1 (es)
JP (3) JP5361109B2 (es)
KR (2) KR20110101254A (es)
CN (2) CN102660539A (es)
AU (2) AU2003276719B2 (es)
BR (1) BR0311768A (es)
CA (1) CA2489346C (es)
CR (1) CR7651A (es)
ES (1) ES2402925T3 (es)
HR (1) HRP20050037A2 (es)
IS (1) IS7640A (es)
LV (1) LV13290B (es)
MA (1) MA27319A1 (es)
MX (1) MXPA04012501A (es)
NO (1) NO20050179L (es)
NZ (1) NZ537617A (es)
PL (1) PL374195A1 (es)
RU (1) RU2406762C2 (es)
WO (1) WO2003106641A2 (es)
ZA (1) ZA200500260B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4753943B2 (ja) 2004-07-13 2011-08-24 ジェン−プローブ・インコーポレーテッド A型肝炎ウイルス核酸の検出のための組成物及び方法
CN100389207C (zh) * 2005-10-27 2008-05-21 中国医学科学院医学生物学研究所 快速、灵敏检测甲肝减毒活疫苗病毒感染性滴度的方法
DE102006034844B3 (de) * 2006-07-27 2007-12-06 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Zusammensetzungen und Verfahren zur Amplifikation von Hepatitis A-Viren (HAV) und/oder Parvoviren B19 (PB19) mittels Multiplex-PCR
JP5257147B2 (ja) * 2008-03-03 2013-08-07 東洋紡株式会社 ラベル
CN101838710A (zh) * 2010-06-04 2010-09-22 湖州市疾病预防控制中心 甲型肝炎病毒核酸荧光定量rt-pcr检测试剂盒及使用方法
TWI435935B (zh) * 2010-12-06 2014-05-01 Univ Nat Cheng Kung 快速檢測標靶核酸片段之套組及方法
PL2643461T3 (pl) * 2011-09-07 2017-09-29 Grifols Therapeutics Inc. Sposoby, kompozycje i zestawy do oznaczania wirusa zapalenia wątroby typu A
CA2877236C (en) * 2012-06-20 2021-03-09 Toray Industries, Inc. Method for detecting nucleic acid and nucleic acid detection kit
JP5993635B2 (ja) * 2012-07-05 2016-09-14 シーアイ化成株式会社 熱収縮性ポリエステル系フィルムおよびその製造方法
EP2743355B1 (en) 2012-12-13 2016-08-10 F. Hoffmann-La Roche AG HAV detection
RU2542968C2 (ru) * 2013-06-25 2015-02-27 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор"" (ФБУН ГНЦ ВБ "Вектор") Набор олигодезоксирибонуклеотидных праймеров и флуоресцентно-меченых днк-зондов для идентификации рнк энтеровирусов, риновирусов, вирусов гепатита а и е из водной среды методом мультиплексной пцр
EP4299763A2 (en) * 2015-09-22 2024-01-03 Biocartis NV Improved detection of short homopolymeric repeats
CN108699597A (zh) * 2015-11-26 2018-10-23 DNAe集团控股有限公司 单分子对照
EP3650553B1 (en) * 2018-11-07 2023-07-12 Siemens Healthcare GmbH Method for detection of specific nucleic acids
CN111690771A (zh) * 2020-06-08 2020-09-22 中联瑞(北京)生物科技有限责任公司 用于检测食品中甲型肝炎病毒恒温扩增的引物组、试剂盒及方法
WO2025263464A1 (ja) * 2024-06-18 2025-12-26 国立大学法人 東京大学 生体分子を検出する方法及びデバイス

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639604A (en) * 1987-09-21 1997-06-17 Gen-Probe Incorporated Homogeneous protection assay
US6004745A (en) * 1987-09-21 1999-12-21 Gen-Probe Incorporated Hybridization protection assay
US5283174A (en) * 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
CA2020958C (en) * 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
AU7224591A (en) * 1990-01-24 1991-08-21 United States of America, as represented by the Secretary, U.S. Department of Commerce, The A rapid and sensitive test for detecting hepatitis a virus
US5200314A (en) * 1990-03-23 1993-04-06 Chiron Corporation Polynucleotide capture assay employing in vitro amplification
JPH07502658A (ja) * 1991-12-23 1995-03-23 バイエル コーポレイション 溶液相サンドイッチハイブリダイゼーションアッセイに用いるためのhavプローブ
RU2031126C1 (ru) * 1992-07-22 1995-03-20 Новосибирский институт биоорганической химии СО РАН Способ детекции рнк вируса гепатита а
US5538848A (en) * 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
EP0975807B1 (en) * 1997-05-02 2006-09-27 Gen-Probe Incorporated Two-step hybridization and capture of a polynucleotide
CA2405952A1 (en) * 2000-05-04 2001-11-08 Syngenta Participations Ag Novel assay for nucleic acid analysis

Also Published As

Publication number Publication date
US20120219941A1 (en) 2012-08-30
ES2402925T3 (es) 2013-05-10
JP2009291200A (ja) 2009-12-17
RU2005100511A (ru) 2005-08-27
JP5361109B2 (ja) 2013-12-04
RU2406762C2 (ru) 2010-12-20
PL374195A1 (en) 2005-10-03
WO2003106641A3 (en) 2004-10-14
CA2489346A1 (en) 2003-12-24
EP1552022B1 (en) 2013-01-23
CA2489346C (en) 2015-07-14
US20040072150A1 (en) 2004-04-15
CN1675378A (zh) 2005-09-28
WO2003106641A2 (en) 2003-12-24
KR20110101254A (ko) 2011-09-15
CR7651A (es) 2006-02-22
AU2009202099A1 (en) 2009-06-18
EP1552022A4 (en) 2006-10-18
IS7640A (is) 2005-01-12
NZ537617A (en) 2006-09-29
JP2005535309A (ja) 2005-11-24
MXPA04012501A (es) 2005-02-17
JP2013208121A (ja) 2013-10-10
ZA200500260B (en) 2006-07-26
HRP20050037A2 (en) 2005-08-31
LV13290B (en) 2005-07-20
AU2003276719B2 (en) 2009-03-12
MA27319A1 (fr) 2005-05-02
BR0311768A (pt) 2005-04-05
KR20050010902A (ko) 2005-01-28
CN102660539A (zh) 2012-09-12
EP1552022A2 (en) 2005-07-13
AU2003276719A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
NO20050179L (no) Identifisering av oligonukleotider for oppfanging, deteksjon og kvantifisering av Hepatitt A viral nukleinsyre
Chaouch Loop‐mediated isothermal amplification (LAMP): an effective molecular point‐of‐care technique for the rapid diagnosis of coronavirus SARS‐CoV‐2
Quiñones-Mateu et al. Deep sequencing: becoming a critical tool in clinical virology
ATE282720T1 (de) Nukleinsäuresequenzen als primer und sonden zur amplifizierung und erkennung von allen hiv-1 subtypen
ATE519861T1 (de) Zusammensetzungen zum nachweis von hepatitis-b- virus
NO923341D0 (no) Fremgangsmaater og reagenser for paavisning av hepatitt c
ATE548464T1 (de) Detektion von nukleinsäuren durch typenspezifische hybrid-capture methode
EP1227161A3 (en) Primers, probes and methods for the detection of nucleic acids of hepatitis C viruses
WO2007016275A3 (en) Methods and compositions for detecting bk virus
WO2003031934A3 (en) Identification of oligonucleotides for the capture, detection and quantitation of hepatitis b viral dna
DE60132924D1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
CY1105782T1 (el) Μέθοδος ενισχύσεως-υβριδισμού για την ανίχνευση και την τυποποίηση του ιού του ανθρώπινου θηλώματος
WO2007076493A3 (en) Methods and reagents for genotyping hcv
ATE362538T1 (de) Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
ATE449194T1 (de) Oligonukleotide zur detektion von hepatitis b viren
DK1689886T3 (da) Molekylær markör associeret med CMV-resistens og anvendelse deraf
DE50107569D1 (de) Nachweis von humanen papillomviren
WO2000066774A3 (en) Improved assay and reagents therefor
DK1284296T3 (da) Fremgangsmåde til påvisning af minority genomer i virus-quasispecies under anvendelse af DNA mikrochips
WO2007059348A3 (en) Compositions and methods for detecting an hcv-1 subtype
ATE315107T1 (de) Verfahren und kit zur früherkennung von krebs
WO2003030624A3 (en) Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
DE602005020761D1 (de) R rna in einem zellfreien system sowie identifizierung von inhibitoren der rna-synthese
ATE321892T1 (de) Hiv-nachweisverfahren und reagenzien dafür
WO2005025408A3 (en) Assay for sars coronavirus by amplification and detection of nucleocapsid rna sequence

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application